Get ready, sports fans! The New York Jets, Cleveland Browns, and Jacksonville Jaguars are trading their home stadiums for a trip across the pond. In 2025, these three NFL teams will play regular-season games in London. The Jaguars are old pros at this, with 14 games under their belt in the UK. They'
The Environmental Protection Agency (EPA) has set new standards for power plants to reduce greenhouse gas emissions. Some experts believe that these reductions can be achieved with only a small increase in costs. This means that while the environment might benefit, the financial impact on power comp
Imagine drilling a hole two miles deep into the frosty heart of Antarctica. That’s exactly what a team of international scientists did, seeking to uncover secrets hidden in ice that’s over a million years old. This ancient ice could reveal how Earth’s climate has changed over time and what role gree
Imagine playing ice hockey in the sunshine! That's what the NHL has planned for 2026. The league is shaking things up by hosting two outdoor games in Florida. On January 2, the Florida Panthers will face the New York Rangers at loanDepot park, home of the Miami Marlins. This will be the first NHL ga
The hockey showdown between the Los Angeles Kings and the Calgary Flames, originally set for Wednesday night at Crypto. com Arena, has been put on hold. Why? The answer lies in the raging Palisades fire that's been sweeping through the region. The blaze, which started on Tuesday, has already scorche
Treatment options for epithelial ovarian cancer (EOC) have expanded a lot in recent years, but much of the progress has been tied to picking the right biomarkers. This means there's still a big need for better treatment options to help patients live longer and enjoy better quality of life. Unlike ma
You might not think about it, but the time of day you get your cancer treatment could make a difference. Scientists have been looking into how our body's internal clock, called the circadian rhythm, affects how well cancer drugs work. One type of drug, called immune checkpoint inhibitors (ICIs), has
Biliary tract cancers, like cholangiocarcinoma and gallbladder cancer, are growing more common worldwide, and most patients get diagnosed when the disease has already advanced, leading to a grim outlook. Recently, combining immune checkpoint inhibitors, such as durvalumab and pembrolizumab, with the
Immune-checkpoint inhibitors (ICIs) have emerged as a powerful tool in the fight against advanced squamous cell lung cancer (LUSC). These drugs offer a glimmer of hope for patients who haven't found success with other treatments. But it's not a one-size-fits-all solution—some patients don't respond
Breast cancer is a tough enemy, and scientists are always looking for new ways to fight it. One important target is a protein called TGFβ RII. This protein helps cancer cells grow and spread. But finding a drug that can block this protein without causing nasty side effects is like finding a needle i
